FMP
Alpha Tau Medical Ltd.
DRTS
NASDAQ
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
2.46 USD
-0.045 (-1.83%)
About
ceo
Mr. Uzi Sofer
sector
Healthcare
industry
Biotechnology
website
https://www.alphatau.com
exchange
NASDAQ
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
CIK
0001871321
ISIN
IL0011839383
CUSIP
M0740A108
Address
5 Kiryat Hamada Street
Phone
972 3 577 4115
Country
IL
Employee
121
IPO Date
Mar 8, 2021
Summary
CIK
0001871321
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
M0740A108
ISIN
IL0011839383
Country
IL
Price
2.46
Beta
0.71
Volume Avg.
31.8k
Market Cap
171.04M
Shares
-
52-Week
2.41-4.8
DCF
0.04
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.85
P/B
-
Website
https://www.alphatau.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest DRTS News
It looks like there's no news available.
